Robert Hofmeister
Förmögenhet: - $ per 2026-07-31
Förmögenhet: - $ per 2026-07-31
Robert Hofmeister currently works at Molkerei Hainichen Freiberg GmbH & Co. KG, as Co-Managing Director.
Dr. Hofmeister also formerly worked at Alaunos Therapeutics, Inc., as Independent Director from 2023 to 2025, EMD Serono Research & Development Institute, Inc., as Global Head-Translational Immunotherapy from 2012 to 2015, and TCR2 Therapeutics, Inc., as Senior Vice President-Research & Development.
Dr. Hofmeister received his doctorate degree from the University of Regensburg.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-04-30 | 0 ( -.--% ) | - $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dairy and cheese products | Verkställande Direktör | - |
| Företag | Position | Slut |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-04-15 |
| TCR2 THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-03-01 |
EMD Serono Research & Development Institute, Inc. | Företagsledare/Principal | 2015-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
University of Regensburg
University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono Research & Development Institute, Inc. | |
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dairy and cheese products | Consumer Non-Durables |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån